Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Large prospective cohort study with hard clinical endpoints (CVD and all-cause mortality), robust adjusted effect sizes, and confirmation across subgroups and sensitivity analyses, but observational design precludes practice-changing status.
This is a planned trial registration with no results reported; the design is sound but enrollment has not yet begun, making it an early-stage study announcement rather than evidence of efficacy.